The Novartis Institutes for Biomedical Research has recently initiated a multi-year project with a group at HSCI headed by Lee Rubin, PhD. The initial focus is the use of small molecule modulators to understand a group of neuromuscular disorders and, ultimately, to find effective therapeutics. This is Novartis’s first academic collaboration with Harvard in the stem cell and regenerative medicine area and, over time, it is anticipated that additional HSCI scientists will be involved. “We are very excited about the collaboration since we know the Novartis scientists extremely well and are looking forward to having very close interactions with them,” Rubin said.
